Customizable DNA labels can selectively guide drug carriers to cancer cells
Scientists at Carnegie Mellon University created a method to use natural cellular delivery systems as targeted carriers for drugs. These custom-made labels can be programmed to guide the drug carriers directly to cancer cells. The approach aims to increase treatment effectiveness and reduce unwanted side effects.
Why it's good news: It could lead to more precise and less damaging cancer treatments.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
A new treatment for cavities is showing promising results in a phase 3 trial, which could lead to FDA approval and reduc…
Researchers have found a previously unknown cause of inflammatory bowel disease that involves antibodies interfering wit…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →